Agilent Technologies Inc (A)

NYSE
Currency in USD
147.36
+2.64(+1.82%)
Closed
Pre Market
148.51+1.15(+0.78%)
A Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
145.20148.46
52 wk Range
124.16155.35
Key Statistics
Edit
Prev. Close
147.36
Open
145.88
Day's Range
145.2-148.46
52 wk Range
124.16-155.35
Volume
3.21M
Average Volume (3m)
1.77M
1-Year Change
12.3%
Book Value / Share
20.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
150.13
Upside
+1.88%
Members' Sentiments
Bearish
Bullish
ProTips
10 analysts have revised their earnings downwards for the upcoming period
Show more

Agilent Technologies Inc Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies Inc SWOT Analysis


Market Resilience
Agilent shows resilience amid challenges, with solid Q2 performance and emerging signs of demand recovery in key markets
Strategic Expansion
Explore Agilent's $925M acquisition of Biovectra, enhancing its CDMO capabilities in GLP-1s, ADCs, HPAPIs, and gene editing
Navigating Headwinds
Delve into Agilent's response to challenges in China and its pharmaceutical segment, including a significant guide cut in May 2024
Future Trajectory
Analyst price targets range from $125 to $135, reflecting cautious optimism about Agilent's growth prospects and market positioning
Read full SWOT analysis

Agilent Technologies Inc Earnings Call Summary for Q4/2024

  • Q3 revenue at $1.578B, down 4.4% YoY; EPS at $1.32, beating guidance by $0.04; operating margin improved to 27.4%
  • Acquisitions of BIOVECTRA and Sigsense completed to enhance capabilities in key growth areas
  • Full-year revenue guidance raised to $6.450B-$6.500B; EPS outlook increased to $5.21-$5.25
  • Q4 revenue expected at $1.641B-$1.691B; EPS projected between $1.38-$1.42, indicating growth at midpoint
  • China revenue down 11% but showing sequential improvement; company expects return to growth in Q4 and into 2025
Last Updated: 23/08/2024, 02:52 am
Read Full Transcript

Compare A to Peers and Sector

Metrics to compare
A
Peers
Sector
Relationship
P/E Ratio
32.6x−3.5x−0.6x
PEG Ratio
5.70−0.840.00
Price/Book
7.1x1.8x2.6x
Price / LTM Sales
6.5x4.8x3.1x
Upside (Analyst Target)
1.8%52.7%54.6%
Fair Value Upside
Unlock9.0%7.7%Unlock

Analyst Ratings

8 Buy
10 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 150.13
(+1.88% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.44
Dividend Yield
0.67%
Industry Median 0.73%
Annualised payout
0.9920
Paid quarterly
5-Years Growth
+7.55%
Growth Streak

Earnings

Latest Release
Nov 25, 2024
EPS / Forecast
1.46 / 1.41
Revenue / Forecast
1.70B / 1.67B
EPS Revisions
Last 90 days

People Also Watch

237.38
BDX
+0.46%
232.71
CME
+0.17%
84.74
GEHC
-0.31%
165.69
KEYS
+0.37%
238.36
DHR
-1.46%

FAQ

What Is the Agilent Technologies (A) Stock Price Today?

The Agilent Technologies stock price today is 147.36

What Stock Exchange Does Agilent Technologies Trade On?

Agilent Technologies is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Agilent Technologies?

The stock symbol for Agilent Technologies is "A."

Does Agilent Technologies Pay Dividends? What’s The Current Dividend Yield?

The Agilent Technologies dividend yield is 0.67%.

What Is the Agilent Technologies Market Cap?

As of today, Agilent Technologies market cap is 42.09B.

What is Agilent Technologies Earnings Per Share?

The Agilent Technologies EPS is 4.44.

What Is the Next Agilent Technologies Earnings Date?

Agilent Technologies will release its next earnings report on 24 Feb 2025.

From a Technical Analysis Perspective, Is A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.